Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127920) titled 'The Impact of Bupivacaine Liposome on Rebound Pain After Total Knee Arthroplasty: A Randomized Controlled Trial' on July 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ganzhou People's Hospital
Condition:
postoperation pain
Intervention:
Liposomal bupivacaine group:10 mL of 0.5% bupivacaine hydrochloride and 10 mL of 1.33% liposomal bupivacaine
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2026-03-18
Target Sample Size: Liposomal bupivacaine group:30;Bupivacaine Hydrochloride Group:30;
Countries of Recruitment:
China
To know more, visit https://www...